A Randomized, open-label, phase 2 study evaluating abemaciclib in combination with irinotecan and temozolomide in patients with relapsed or refractory Ewing sarcoma

EMC - Otorinolaringoiatria · Elsevier

Аннотация

Publication date: June 2026 Source: EJC Paediatric Oncology, Volume 7 Author(s): Alba Rubio-San-Simon, Marilena Cesari, Melissa Bear, Cristina Mata, Ayumu Arakama, Holly Knoderer, Amanda Sykes, Jonathan Boss, Gertjan van Hal, Antoine Italiano

Читать у издателя →

Похожие статьи